Glycemic Characteristics and Neonatal Outcomes of Women Treated for Mild Gestational Diabetes
- 1 April 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 117 (4), 819-827
- https://doi.org/10.1097/aog.0b013e31820fc6cf
Abstract
OBJECTIVE: To estimate the association between fasting and 2-hour postprandial blood glucose levels and neonatal outcomes in women treated for mild gestational diabetes. METHODS: In this secondary analysis of a multicenter randomized treatment trial of mild gestational diabetes, the median fasting and 2-hour postprandial glucose levels were analyzed in 2-week intervals and change over time (slope) was calculated for women with gestational diabetes (abnormal oral glucose tolerance test) and a fasting glucose less than 95 mg/dL who received nutritional management with self blood glucose monitoring and insulin as needed. Regression analyses were performed to estimate the relationship between median fasting and postprandial glucose and neonatal fat mass, cord blood C-peptide, birth weight, large-for-gestational-age neonates, macrosomia (greater than 4,000 g), and neonatal hypoglycemia. RESULTS: Among 460 women with gestational diabetes, median fasting (P<.001), postprandial breakfast (P<.001), and postprandial lunch (P<.001) glucose values declined over the treatment period, whereas postprandial dinner values remained stable (P=.83). Higher median fasting glucose during the first 2 weeks of treatment was significantly associated with increased odds ratios for neonatal fat mass (1.35; 95% CI 1.09–1.66; P=.006) and elevated C-peptide (1.29; CI 1.09–1.52; P=.003). Higher median fasting glucose during the last 2 weeks before delivery was associated with higher rates of large-for-gestational-age neonates (1.27; CI 1.05–1.53; P=.01), macrosomia (1.32; CI 1.04–1.65; P = .02), and elevated C-peptide (1.19; CI 1.03–1.38; P=.02). CONCLUSION: In women treated for mild gestational diabetes, higher fasting glucose during initiation of diet therapy was associated with increased neonatal fat mass and elevated C-peptide and during the last 2 weeks before delivery with macrosomia, large-for-gestational age, and elevated C-peptide. LEVEL OF EVIDENCE: IIKeywords
This publication has 18 references indexed in Scilit:
- A Multicenter, Randomized Trial of Treatment for Mild Gestational DiabetesNew England Journal of Medicine, 2009
- Metabolic Syndrome in Childhood: Association With Birth Weight, Maternal Obesity, and Gestational Diabetes MellitusPediatrics, 2005
- Evaluation of body composition of large-for-gestational-age infants of women with gestational diabetes mellitus compared with women with normal glucose tolerance levelsAmerican Journal of Obstetrics and Gynecology, 2004
- Increased fetal adiposity: A very sensitive marker of abnormal in utero developmentAmerican Journal of Obstetrics and Gynecology, 2003
- Relationship of neonatal body composition to maternal glucose control in women with gestational diabetes mellitusThe Journal of Maternal-Fetal & Neonatal Medicine, 2002
- Effects of maternal gestational diabetes on offspring adiposity at 4-7 years of age.Diabetes Care, 1999
- 1994–1996 U.S. Singleton Birth Weight Percentiles for Gestational Age by Race, Hispanic Origin, and GenderMaternal and Child Health Journal, 1999
- Gestational Diabetes Mellitus and Impaired Glucose Tolerance During Pregnancy: Long-Term Effects on Obesity and Glucose Tolerance in the OffspringDiabetes, 1985
- Excessive Obesity in Offspring of Pima Indian Women with Diabetes during PregnancyNew England Journal of Medicine, 1983
- SUBCUTANEOUS FAT IN NEWBORN INFANTS OF DIABETIC MOTHERS: AN INDICATION OF QUALITY OF DIABETIC CONTROLThe Lancet, 1977